Non-compartmental analysis.

When analyzing pharmacokinetic data, one generally employs either model fitting using nonlinear regression analysis or non-compartmental analysis techniques (NCA). The method one actually employs depends on what is required from the analysis. If the primary requirement is to determine the degree of exposure following administration of a drug (such as AUC), and perhaps the drug's associated pharmacokinetic parameters, such as clearance, elimination half-life, T (max), C (max), etc., then NCA is generally the preferred methodology to use in that it requires fewer assumptions than model-based approaches. In this chapter we cover NCA methodologies, which utilize application of the trapezoidal rule for measurements of the area under the plasma concentration-time curve. This method, which generally applies to first-order (linear) models (although it is often used to assess if a drug's pharmacokinetics are nonlinear when several dose levels are administered), has few underlying assumptions and can readily be automated.In addition, because sparse data sampling methods are often utilized in toxicokinetic (TK) studies, NCA methodology appropriate for sparse data is also discussed.

[1]  L. Benet,et al.  An integrated approach to pharmacokinetic analysis for linear mammillary systems in which input and exit may occur in/from any compartment , 1989, Journal of Pharmacokinetics and Biopharmaceutics.

[2]  L. Benet,et al.  General treatment of mean residence time, clearance, and volume parameters in linear mammillary models with elimination from any compartment , 1988, Journal of Pharmacokinetics and Biopharmaceutics.

[3]  Steven G. Woolfrey,et al.  Analysis of Toxicokinetic Data Using NONMEM: Impact of Quantification Limit and Replacement Strategies for Censored Data , 2001, Journal of Pharmacokinetics and Pharmacodynamics.

[4]  Rowland and Tozer,et al.  Comprar Clinical Pharmacokinetics: Concepts and Applications, 4/e | Rowland and Tozer | 9780781750097 | Lippincott Williams & Wilkins , 2010 .

[5]  Malcolm Rowland,et al.  Clinical Pharmacokinetics and Pharmacodynamics: Concepts and Applications , 1980 .

[6]  L. Benet,et al.  Noncompartmental determination of the steady-state volume of distribution. , 1979, Journal of pharmaceutical sciences.

[7]  J. Nedelman,et al.  An extension of Satterthwaite's approximation applied to pharmacokinetics. , 1998, Journal of biopharmaceutical statistics.

[8]  X. H. Huang,et al.  Johan Gabrielsson, Daniel Weiner. Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications, Fourth Edition , 2010 .

[9]  A. John Bailer,et al.  Testing for the equality of area under the curves when using destructive measurement techniques , 1988, Journal of Pharmacokinetics and Biopharmaceutics.

[10]  L. Benet,et al.  General treatment of linear mammillary models with elimination from any compartment as used in pharmacokinetics. , 1972, Journal of pharmaceutical sciences.

[11]  W R Gillespie,et al.  Noncompartmental Versus Compartmental Modelling in Clinical Pharmacokinetics , 1991, Clinical pharmacokinetics.

[12]  L. Benet,et al.  Determination of mean input time, mean residence time, and steady-state volume of distribution with multiple drug inputs , 1989, Journal of Pharmacokinetics and Biopharmaceutics.

[13]  K. Pang,et al.  A review of metabolite kinetics , 1985, Journal of Pharmacokinetics and Biopharmaceutics.

[14]  Daniel J. Holder COMMENTS ON NEDELMAN AND JIA'S EXTENSION OF SATTERTHWAITE'S APPROXIMATION APPLIED TO PHARMACOKINETICS , 2001, Journal of biopharmaceutical statistics.